Clinical Cardiology Alert – October 1, 2009
October 1, 2009
View Issues
-
Atorvastatin Reload Prior to PCI for Patients on Chronic Statin Therapy
The ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) series of randomized, controlled trials has assessed the role of atorvastatin loading prior to percutaneous coronary intervention (PCI) in both stable and unstable coronary syndromes. -
New data on Warfarin Therapy for Atrial Fibrillation
Current recommendations for stroke prophylaxis with warfarin for patients with atrial fibrillation do not take into account the risks of hemorrhage. -
A New Antiplatelet Agent for Patients with ACS
Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for patients suffering an acute coronary syndrome (ACS). However, there remains a significant incidence of recurrent ACS and mortality even in patients treated with dual antiplatelet therapy. -
AED Placement and Effectiveness
Folke et al from Copenhagen, Denmark, studied the consequences of automatic external defibrillator (AED) placement in a large metropolitan area. -
Improved Outcomes and Reduction of CV Risk in Diabetes Remains Problematic
Do patients with diabetes share in the reduction of cardiovascular (CV) risk factors as much as non-diabetics? -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.